2014
DOI: 10.1007/s00270-014-0971-5
|View full text |Cite
|
Sign up to set email alerts
|

Percutaneous Sclerotherapy of Congenital Slow-Flow Vascular Malformations of the Orbit

Abstract: Congenital slow-flow vascular malformations of the orbital region are rare lesions that should be treated using a multidisciplinary approach. Monitoring of the intraorbital pressure is required both during and after the procedure to decide about the need for lateral canthotomy to reduce the transiently increased intraorbital pressure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
13
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 15 publications
(13 citation statements)
references
References 6 publications
0
13
0
Order By: Relevance
“…This is important especially concerning the known risk of vision loss and orbital compartment syndrome. 6,7 Because of that, we believe it is important to perform orbital sclerotherapy with the support of a multidisciplinary team to ensure an early decompression in the case of compartment syndrome. These findings are important as they provide important information regarding the risks and benefits of percutaneous sclerotherapy for vascular malformations of the orbit and periocular region.…”
Section: Discussionmentioning
confidence: 99%
“…This is important especially concerning the known risk of vision loss and orbital compartment syndrome. 6,7 Because of that, we believe it is important to perform orbital sclerotherapy with the support of a multidisciplinary team to ensure an early decompression in the case of compartment syndrome. These findings are important as they provide important information regarding the risks and benefits of percutaneous sclerotherapy for vascular malformations of the orbit and periocular region.…”
Section: Discussionmentioning
confidence: 99%
“…Complications during or following sclerotherapy were not observed in our study. In humans, there is a low complication rate following sclerotherapy as monotherapy of orbital and periocular venous malformations, with reported complications including swelling, discomfort, skin erythema, skin necrosis, scar formation, orbital compartment syndrome, vision loss, reduced infraorbital nerve sensation, 10 and most commonly, the need for repeated treatments for resolution 11 . Adverse effects reflect differences in technique, severity of disease, and sclerosing agents used 12 …”
Section: Discussionmentioning
confidence: 99%
“…Commonly, a mixture of the sclerosant and contrast agent is used. Application of manual pressure may also be performed to prevent sclerosant from entering a draining vein that may result in non‐target sclerosis 10–12 . There are currently no reports of sclerotherapy, as monotherapy being used to treat an orbital venous malformation in any animal.…”
Section: Introductionmentioning
confidence: 99%
“…Chiramel and colleagues selected ten patients with orbital venous-lymphatic lesions and reported resolution of lesion in all patients by injecting STS in the digital subtraction angiography suite 12 . Hill et al.…”
Section: Discussionmentioning
confidence: 99%